Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing to sign and date a consent form agreeing to take part
- People who are willing to follow all study procedures and are available for the full duration of the study
- People who are male (biological sex) and aged 18 or older
- People who have been diagnosed with prostate cancer
- People who are currently receiving androgen deprivation therapy (ADT) — a treatment that uses medicine or surgery to lower testosterone levels in the body to treat prostate cancer
- People whose testosterone levels have been reduced to a very low level as a result of ADT, confirmed by either a blood test result or a pattern of falling PSA (a prostate cancer marker) without signs of it rising again (confirm with trial site)
- People whose ADT treatment is expected to continue for at least 4 weeks from the time of joining the study
- People who experience hot flushes or night sweats (known as vasomotor symptoms) that started after beginning ADT and happen at least once a day
- People who own a compatible smartphone — either an iPhone 8 or newer running iOS 16.0 or higher, or an Android phone running version 12 or higher — with Bluetooth 5, and who are willing to use mobile data or Wi-Fi and download the Empatica Care app
- People who can read, speak, and understand English
- People who are generally well enough to carry out everyday activities, with only mild limitations at most (this is measured on a standard scale called ECOG — confirm with trial site)
Who may not be able to join:
- People whose wrist measurement is smaller than 95 mm or larger than 222 mm, as the study watch may not fit properly
- People who have a known skin allergy to silicone, which is a material used in the study smartwatch
- People who experienced hot flushes or night sweats before they started ADT treatment
- People who currently have a fever above 38°C or are being treated for a fever-related illness
- People who are unable to press the button on the side of the study smartwatch
- People who are currently taking part in another experimental treatment trial for prostate cancer
- People whose prostate cancer shows signs of progressing or getting worse based on specific measurement criteria (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Michael Devitt, MD, University of Virginia
Phone: 434-421-5577
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Duration of wear per day; Percent of days with self-reported time marked vasomotor events; Concordance between time marked vasomotor events and events described through EMAs.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.